COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 7, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Hypertension Awareness and Control Improved with Better Access to Primary Care, New Study Finds
Regardless of where individuals live, they may benefit from blood pressure control programs that increase access to primary health care, study authors suggest.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 6, 2022
DASH Diet, Weight Loss, Exercise and Other Nondrug Strategies to Manage Hypertension
Find out how effective these 3 and 5 additional ACC/AHA-recommended non-drug interventions are at reducing BP (in mm Hg) in adults with hypertension and with normal BP.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 2, 2022
High HDL-C Increases CV Risk in Men with Hypertension, Study Finds
In patients with hypertension, HDL-C >80 mg/dL was linked to a greater risk for CV events among men but not among women. Protective?
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 31, 2022
Primary Care Month in Review: 6 Popular Stories from August 2022
Use of exercise trackers associated with improved physical activity, FDA recommends repeat at-home COVID-19 antigen testing, and 4 more top content from August.
FDA Authorizes Pfizer and Moderna Updated COVID-19 Booster Shots
The FDA EUA amendments for updated booster vaccinations are based on clinical studies of the omicron BA.1 variant and preclinical data on the BA.4 and BA.5 variants.
Polypill Reduces Risk of MACE in Secondary Prevention for Older Adults: Results from SECURE
Taking a 3-drug polypill (aspirin, ACEi, statin) vs each of the drugs separately reduced risk for a major CV event by 33%, according to results of the SECURE trial.
The Future of US Antimicrobial Resistance is in Our Hands and There is Work to Do
Steer clear of antibiotic Rxs whenever possible, says Anne Meneghetti, MD, to help the US get back to pre-COVID levels of antimicrobial stewardship.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 30, 2022
Specific Blood Pressure Thresholds Not Needed When Selecting Patients with T2D for Antihypertensive Treatment, Suggests New Research
Blood pressure-lowering therapy reduced the risk of major CV events in persons with and without type 2 diabetes, according to an individual participant-level data meta-analysis.
8 Key Drivers of Hypertension Control & How to Improve Them
These 8 drivers of BP control reflect study of high-performing health systems and the strategies that have led to successful large scale hypertension management.
Primary Care Can Help Restore US Antibiotic Stewardship, Starting with Flu Shots
Preventing viral infections with vaccination can keep the most vulnerable out of the hospital, reducing the risk of bacterial superinfections.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 29, 2022
Primary Viewpoints Episode 18: Why Humor Can be the Best Medicine for Clinicians
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Ernest R. Gelb, DO, 126th president of the American Osteopathic Association.
Superinfection Rate in Hospitalized COVID-19 Patients was Found to be Low
Only 9% of inpatients with COVID-19 had a bacterial superinfection that could be treated with antibiotics which curbed use of broad-spectrum antimicrobials.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 26, 2022
Pfizer Reports Positive Topline Phase 3 Data for Bivalent RSV Vaccine in Older Adults
Pfizer announced that a single dose of the vaccine, RSVpreF, demonstrated 85.7% efficacy against severe disease, defined by ≥3 symptoms.
